These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 8039760

  • 1. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G, Galloni E, Dri AV, Rodeghiero F.
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y, Abe T.
    Thromb Haemost; 1981 Dec 23; 46(4):706-9. PubMed ID: 7330820
    [Abstract] [Full Text] [Related]

  • 4. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 23; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 5. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G, Monotti R, Haeberli A, Straub PW.
    Thromb Haemost; 1987 Aug 04; 58(2):758-63. PubMed ID: 3672428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G, Fiori G, Monotti R, Haeberli A, Straub PW.
    J Lab Clin Med; 1993 Jan 04; 121(1):83-90. PubMed ID: 8426084
    [Abstract] [Full Text] [Related]

  • 8. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T.
    Hokkaido Igaku Zasshi; 1982 May 04; 57(3):351-63. PubMed ID: 6957368
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G, Roux A, Haeberli A, Straub PW.
    Blood; 1982 Aug 04; 60(2):381-8. PubMed ID: 7093524
    [Abstract] [Full Text] [Related]

  • 10. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M, Hardin J, Burton J, Lee L, Haber E, Bloch KJ.
    J Clin Invest; 1976 Jul 04; 58(1):142-51. PubMed ID: 932202
    [Abstract] [Full Text] [Related]

  • 11. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
    Mombelli G, Roux A, Hofmann V, Straub PW.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1901. PubMed ID: 531571
    [Abstract] [Full Text] [Related]

  • 12. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L.
    Leukemia; 1993 Jan 08; 7(1):2-9. PubMed ID: 8418375
    [Abstract] [Full Text] [Related]

  • 13. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z, Osman E, Hutton RA, Burroughs AK.
    Am J Gastroenterol; 1999 Oct 08; 94(10):2977-82. PubMed ID: 10520855
    [Abstract] [Full Text] [Related]

  • 14. [Coagulation tests in septic surgical patients].
    Oberhofer D, Kucisec-Tepes N, Skok J, Vucić N, Cala K.
    Acta Med Croatica; 2004 Oct 08; 58(5):389-94. PubMed ID: 15756805
    [Abstract] [Full Text] [Related]

  • 15. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 08; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 16. [Antithrombin III substitution in patients in shock].
    Vinazzer H, Blauhut B, Bergmann H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Jan 08; 111(6):806-16. PubMed ID: 6083957
    [Abstract] [Full Text] [Related]

  • 17. Measurement of fibrinopeptide A in human blood.
    Nossel HL, Yudelman I, Canfield RE, Butler VP, Spanondis K, Wilner GD, Qureshi GD.
    J Clin Invest; 1974 Jul 08; 54(1):43-53. PubMed ID: 4600045
    [Abstract] [Full Text] [Related]

  • 18. Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y, Nakamura H, Abe T.
    Bibl Haematol; 1983 Jul 08; (49):163-72. PubMed ID: 6667244
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec 08; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the disappearance curve of labelled fibrinogen at the time of hyperfibrinogenemia in rabbits with acute or chronic intravascular coagulation.
    Hasegawa H, Watanabe N, Nagata H, Murao M.
    Thromb Haemost; 1976 Aug 31; 36(1):49-59. PubMed ID: 1036828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.